Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine care
| dc.contributor.author | Ørnbjerg, Lykke Midtbøll | |
| dc.contributor.author | Rugbjerg, Kathrine | |
| dc.contributor.author | Georgiadis, Stylianos | |
| dc.contributor.author | Rasmussen, Simon Horskjær | |
| dc.contributor.author | Jacobsson, Lennart | |
| dc.contributor.author | Loft, Anne Gitte | |
| dc.contributor.author | Iannone, Florenzo | |
| dc.contributor.author | Fagerli, Karen Minde | |
| dc.contributor.author | Vencovsky, Jiri | |
| dc.contributor.author | Santos, Maria José | |
| dc.contributor.author | Möller, Burkhard | |
| dc.contributor.author | Pombo-Suarez, Manuel | |
| dc.contributor.author | Rotar, Ziga | |
| dc.contributor.author | Gudbjornsson, Bjorn | |
| dc.contributor.author | Cefle, Ayse | |
| dc.contributor.author | Eklund, Kari | |
| dc.contributor.author | Codreanu, Catalin | |
| dc.contributor.author | Jones, Gareth | |
| dc.contributor.author | van der Sande, Marleen | |
| dc.contributor.author | Wallman, Johan Karlsson | |
| dc.contributor.author | Sebastiani, Marco | |
| dc.contributor.author | Michelsen, Brigitte | |
| dc.contributor.author | Závada, Jakub | |
| dc.contributor.author | Nissen, Michael John | |
| dc.contributor.author | Sanchez-Piedra, Carlos | |
| dc.contributor.author | Tomšič, Matija | |
| dc.contributor.author | Love, Thorvardur Jon | |
| dc.contributor.author | Relas, Heikki | |
| dc.contributor.author | Mogosan, Corina | |
| dc.contributor.author | Hetland, Merete Lund | |
| dc.contributor.author | Østergaard, Mikkel | |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2024-11-18T16:22:01Z | |
| dc.date.available | 2024-11-18T16:22:01Z | |
| dc.date.issued | 2024-04-01 | |
| dc.description | On behalf of the EuroSpA Scientific Committee, the authors acknowledge Novartis Pharma AG and IQVIA for supporting the EuroSpA Research Collaboration Network | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 12 | |
| dc.format.extent | 4090047 | |
| dc.identifier | 283924437 | |
| dc.identifier | d9bd5f6c-44f5-4a22-8708-7d3a2662bfb7 | |
| dc.identifier | 38224992 | |
| dc.identifier | 85189795030 | |
| dc.identifier.citation | Ørnbjerg, L M, Rugbjerg, K, Georgiadis, S, Rasmussen, S H, Jacobsson, L, Loft, A G, Iannone, F, Fagerli, K M, Vencovsky, J, Santos, M J, Möller, B, Pombo-Suarez, M, Rotar, Z, Gudbjornsson, B, Cefle, A, Eklund, K, Codreanu, C, Jones, G, van der Sande, M, Wallman, J K, Sebastiani, M, Michelsen, B, Závada, J, Nissen, M J, Sanchez-Piedra, C, Tomšič, M, Love, T J, Relas, H, Mogosan, C, Hetland, M L & Østergaard, M 2024, 'Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine care', The Journal of rheumatology, vol. 51, no. 4, pp. 378–389. https://doi.org/10.3899/jrheum.2023-0764 | en |
| dc.identifier.doi | 10.3899/jrheum.2023-0764 | |
| dc.identifier.iss | 4 | en |
| dc.identifier.issn | 0315-162X | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/153542684 | |
| dc.identifier.uri | https://hdl.handle.net/2164/24635 | |
| dc.identifier.vol | 51 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | The Journal of rheumatology | en |
| dc.subject | epidemiology | en |
| dc.subject | fatigue | en |
| dc.subject | pain | en |
| dc.subject | psoriatic arthritis | en |
| dc.subject | tumor necrosis factor inhibitors | en |
| dc.subject | R Medicine | en |
| dc.subject | Supplementary Data | en |
| dc.subject | https://www.jrheum.org/highwire/filestream/45020/field_highwire_adjunct_files/0/2023-0764DataSuppl.pdf | en |
| dc.subject.lcc | R | en |
| dc.title | Patient-reported outcomes and PRO remission rates in 12,262 biologic-naïve patients with psoriatic arthritis treated with TNF-inhibitors in routine care | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Ornbjerg_etal_TJR_Patient-reported_outcomes_PRO_VOR.pdf
- Size:
- 3.9 MB
- Format:
- Adobe Portable Document Format
